GlassScriptPhysician profile
Taniesha Buffin
NPI 1114107836
$1,650.97
in general payments reported to CMS, 2019-2025
21 companies · $47.31 in 2025
The $47.31 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $22.59 · 2022: $587 · 2023: $717 · 2024: $16.11 · 2025: $47.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $780.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $380.69 | 2022-2023 | |
| Abbvie INC. | $308.68 | 2019-2023 | Lo Loestrin Fe, Linzess, Viberzi |
| Abbott Laboratories | $166.23 | 2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $140.38 | 2019-2023 | |
| Astellas Pharma US INC | $95.32 | 2019-2024 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $77.97 | 2022 | |
| Amgen INC. | $75.97 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.52 | 2022 | |
| Therapeuticsmd, INC. | $49.26 | 2019-2022 | |
| Hologic Sales and Service, LLC | $47.31 | 2025 | Myosure Tissue Removal Device |
| Novartis Pharmaceuticals Corporation | $36.78 | 2019 | |
| Lilly USA, LLC | $32.90 | 2022 | |
| Pfizer INC. | $30.72 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.72 | 2022 | |
| Daiichi Sankyo INC. | $22.77 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $22.43 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $22.07 | 2023 | Rexulti |
| Sumitomo Pharma America, INC. | $16.79 | 2023 | Myfembree |
| Dexcom, INC. | $15.82 | 2023 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $15.50 | 2023 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $14.14 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taniesha Buffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.